📣 Help Shape the Future of UKRI's Gateway to Research (GtR)

We're improving UKRI's Gateway to Research and are seeking your input! If you would be interested in being interviewed about the improvements we're making and to have your say about how we can make GtR more user-friendly, impactful, and effective for the Research and Innovation community, please email gateway@ukri.org.

Towards developing criteria for scleroderma renal crisis: A scoping review. (2017)

First Author: Hoa S

Attributed to: MICA: Evaluation of the selective endothelin A-receptor antagonist zibotentan as a treatment for renal disease in systemic sclerosis (scleroderma) funded by MRC

Abstract

No abstract provided

Bibliographic Information

Digital Object Identifier: http://dx.doi.org/10.1016/j.autrev.2017.02.012

PubMed Identifier: 28212921

Publication URI: http://europepmc.org/abstract/MED/28212921

Type: Journal Article/Review

Volume: 16

Parent Publication: Autoimmunity reviews

Issue: 4

ISSN: 1568-9972